HDMP-28
From Wikipedia, the free encyclopedia
|
HDMP-28
|
|
| Systematic (IUPAC) name | |
| methyl (2R)-2-naphthalen-2-yl-2-[(2R)-piperidin-2-yl]acetate | |
| Identifiers | |
| CAS number | ? |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | C18H21NO2 |
| Mol. mass | 283.365 |
| SMILES | & |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
HDMP-28 is a piperidine based stimulant drug. It is closely related to dexmethylphenidate, but with the phenyl ring replaced by naphthalene. It is a potent dopamine reuptake inhibitor, with several times the potency of methylphenidate and a short duration of action,[1] and is a structural isomer of another potent dopamine reuptake inhibitor, (-)-Methyl-1-methyl-4β-(2-naphthyl)piperidine-3β-carboxylate.
[edit] References
- ^ Lile JA, Wang Z, Woolverton WL, France JE, Gregg TC, Davies HM, Nader MA. The reinforcing efficacy of psychostimulants in rhesus monkeys: the role of pharmacokinetics and pharmacodynamics. Journal of Pharmacology and Experimental Therapeutics. 2003 Oct;307(1):356-66. PMID 12954808

